您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
PRO / Antibodies

FITC Anti-Human CD44 Antibody

FITC Anti-Human CD44 Antibody

英诺赛图(InnoCyto)的 FITC Anti-Human CD44 Antibody(克隆 BJ18) 为鼠源 IgG1 单克隆抗体,靶向 CD44(别名 H-CAM 等),FITC 标记(488 nm 蓝色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,015 起,仅供科研使用(RUO)。

生物试剂 供应商 上海英诺赛图 ↗ 型号 120303 更新 2026-11-12
参考价格区间
¥1,015
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 FITC Anti-Human CD44 Antibody(克隆 BJ18) 为鼠源 IgG1 单克隆抗体,靶向 CD44(别名 H-CAM 等),FITC 标记(488 nm 蓝色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,015 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

120303 | 25 tests | ¥1,015

120304 | 100 tests | ¥2,235

Product Details

Regulatory Status|RUO

Protein Concentration|Supplied at a lot-specific concentration.

Storage & Handling|The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Recommended Usage|For flow cytometric staining, it is recommended to use 5 µL of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application. FITC has an excitation max at 493 nm and an emission max at 525 nm.

See All Formats|Clone BJ18

Background Information

Human CD44 is a widely expressed type I transmembrane glycoprotein that functions as a cell adhesion molecule involved in cell-cell and cell-extracellular matrix interactions. It is expressed on numerous cell types, including leukocytes, epithelial cells, fibroblasts, endothelial cells, and many stem cells. CD44 regulates a broad range of biological processes, including lymphocyte activation and homing, leukocyte migration, tissue repair, hematopoiesis, and wound healing. Through its ability to mediate adhesion and intracellular signaling, CD44 also influences cell proliferation, survival, differentiation, and motility.

Structurally, CD44 consists of an extracellular N-terminal hyaluronan-binding domain, a stem region that undergoes extensive alternative splicing, a single transmembrane domain, and a cytoplasmic tail that interacts with cytoskeletal adaptor proteins such as ezrin, radixin, and moesin (ERM proteins). Alternative splicing generates numerous CD44 variant isoforms (CD44v), which differ in their extracellular domains and tissue distribution. The principal ligand for CD44 is hyaluronic acid (hyaluronan), a major component of the extracellular matrix. CD44 also binds osteopontin, fibronectin, collagen, laminin, matrix metalloproteinases, and select growth factors, allowing it to integrate extracellular matrix remodeling with intracellular signaling pathways.

CD44 has been implicated in numerous inflammatory, autoimmune, and malignant diseases. In chronic inflammatory disorders such as rheumatoid arthritis and inflammatory bowel disease, CD44 contributes to leukocyte recruitment and tissue inflammation. In cancer, CD44 is frequently overexpressed and serves as a marker of cancer stem cells in multiple tumor types, including breast, colorectal, pancreatic, gastric, and head and neck cancers. CD44 promotes tumor cell proliferation, epithelial-mesenchymal transition, invasion, metastasis, resistance to chemotherapy, and tumor recurrence through signaling pathways involving Ras, PI3K/AKT, Wnt/β-catenin, and receptor tyrosine kinases. Consequently, CD44 has emerged as an attractive therapeutic target. Investigational strategies include monoclonal antibodies, hyaluronan-targeted drug delivery systems, antibody-drug conjugates, nanoparticle-based therapies, CAR T-cell approaches, and inhibitors that disrupt CD44-hyaluronan interactions. These therapies aim to selectively eliminate CD44-expressing tumor cells, overcome drug resistance, and enhance the effectiveness of conventional cancer treatments while preserving normal tissue function.

Data Sheets

Human peripheral blood lymphocytes were stained with FITC Anti-Human CD44 clone BJ18 (color-filled histogram) or an isotype control (gray histogram).

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格25 tests
CloneBJ18
ApplicationFlow Cytometry
ReactivityHuman
FormatFITC
Target NameCD44, H-CAM, Ly-24, gp85
Isotypemouse IgG1
Antibody TypeMonoclonal
Regulatory StatusRUO
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA
Protein ConcentrationSupplied at a lot-specific concentration.
Excitation LaserBlue Laser (488 nm)
目录价¥1,015

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). FITC Anti-Human CD44 Antibody(120303)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/fitc-anti-human-cd44-antibody.html.
TeleVM. (2026, November 12). FITC Anti-Human CD44 Antibody(120303). 产品目录. https://www.suprotek.cn/products/item/fitc-anti-human-cd44-antibody.html
@misc{biocsp_item_fitc_anti_human_cd44_antibody,
  title        = {FITC Anti-Human CD44 Antibody(120303)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/fitc-anti-human-cd44-antibody.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

FITC Anti-Human CD44 Antibody

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。